Shares in Anika Therapeutics (NSDQ:ANIK) fell today after the orthopedics company missed expectations on Wall Street with its 1st quarter results.
The Bedford, Mass.-based company posted profits of $5.5 million, or 37¢ per share, on sales of $23.4 million for the 3 months ended March 31, for bottom-line loss of -20.3% on sales growth of 4.9% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Anika misses Q1 earnings by a penny appeared first on MassDevice.
from MassDevice http://ift.tt/2pcyeSx
Cap comentari:
Publica un comentari a l'entrada